AC Immune reports Phase 2 data showing stabilized Parkinson's biomarkers, strong antibody response, and a potential slowing ...
Explore the Coyote V8’s development, all-generation updates, supercharged variants, and common issues that make this Ford ...
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
Data demonstrates neflamapimod treatment led to significant reductions in plasma glial fibrillary acidic protein ( GFAP), a key marker of neuroinflammation-associated neurodegeneration, and increased ...
Following on from the excellent Born, the Cupra Raval ticks just about all of the right boxes when it comes to electric ...
Sport Fishing Mag on MSN
The evolution of outboard engines
From high horsepower to alternative fueling options, modern outboard engines are evolving down multiple paths. The post The ...
Jon Kotwicki jokes that converting an aluminum plane in Alaska is the “worst idea that a person could possibly have.” ...
D-Orbit’s ION vehicles were launched Nov. 28 from Vandenberg Space Force Base in California. The two ION satellite carrier ...
CREXONT is Amneal’s next-generation extended-release CD/LD formulation that uses a novel mucoadhesive polymer designed to optimize levodopa delivery and absorption, providing the longest-lasting ...
Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...
Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single infusion as early as second lineData suggest ...
Volvo doesn’t do new XC90s very often – this is only the second generation since 2002. The latest update to the plug-in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results